6.
Sbeit W, Khoury T, Goldin E, Mahamid M
. Three-months duration of fully-covered metal stent for refractory dominant extra-hepatic biliary stricture among primary sclerosing cholangitis patients: efficacy and safety. Surg Endosc. 2021; 36(4):2412-2417.
DOI: 10.1007/s00464-021-08522-x.
View
7.
Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D
. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl. 2009; 15(3):330-40.
DOI: 10.1002/lt.21679.
View
8.
Gluck M, Cantone N, Brandabur J, Patterson D, Bredfeldt J, Kozarek R
. A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis. J Clin Gastroenterol. 2008; 42(9):1032-9.
DOI: 10.1097/MCG.0b013e3181646713.
View
9.
Sidhu R, Turnbull D, Newton M, Thomas-Gibson S, Sanders D, Hebbar S
. Deep sedation and anaesthesia in complex gastrointestinal endoscopy: a joint position statement endorsed by the British Society of Gastroenterology (BSG), Joint Advisory Group (JAG) and Royal College of Anaesthetists (RCoA). Frontline Gastroenterol. 2019; 10(2):141-147.
PMC: 6540268.
DOI: 10.1136/flgastro-2018-101145.
View
10.
Natt N, Michael F, Michael H, Dubois S, Al Mazroui A
. ERCP-Related Adverse Events in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis. Can J Gastroenterol Hepatol. 2022; 2022:2372257.
PMC: 9334029.
DOI: 10.1155/2022/2372257.
View
11.
Chapman M, Webster G, Bannoo S, Johnson G, Wittmann J, Pereira S
. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience. Eur J Gastroenterol Hepatol. 2012; 24(9):1051-8.
PMC: 3584158.
DOI: 10.1097/MEG.0b013e3283554bbf.
View
12.
Heimbach J, Sanchez W, Rosen C, Gores G
. Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford). 2011; 13(5):356-60.
PMC: 3093648.
DOI: 10.1111/j.1477-2574.2011.00298.x.
View
13.
Arechederra M, Rullan M, Amat I, Oyon D, Zabalza L, Elizalde M
. Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures. Gut. 2021; 71(6):1141-1151.
PMC: 9120390.
DOI: 10.1136/gutjnl-2021-325178.
View
14.
Gerges C, Beyna T, Tang R, Bahin F, Lau J, van Geenen E
. Digital single-operator peroral cholangioscopy-guided biopsy sampling versus ERCP-guided brushing for indeterminate biliary strictures: a prospective, randomized, multicenter trial (with video). Gastrointest Endosc. 2019; 91(5):1105-1113.
DOI: 10.1016/j.gie.2019.11.025.
View
15.
Adler D, Haseeb A, Francis G, Kistler C, Kaplan J, Ghumman S
. Efficacy and safety of therapeutic ERCP in patients with cirrhosis: a large multicenter study. Gastrointest Endosc. 2015; 83(2):353-9.
DOI: 10.1016/j.gie.2015.08.022.
View
16.
Khashab M, Chithadi K, Acosta R, Bruining D, Chandrasekhara V, Eloubeidi M
. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2014; 81(1):81-9.
DOI: 10.1016/j.gie.2014.08.008.
View
17.
Njei B, McCarty T, Varadarajulu S, Navaneethan U
. Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Aliment Pharmacol Ther. 2016; 44(11-12):1139-1151.
DOI: 10.1111/apt.13817.
View
18.
Bowlus C, Arrive L, Bergquist A, Deneau M, Forman L, Ilyas S
. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2022; 77(2):659-702.
DOI: 10.1002/hep.32771.
View
19.
Ishii Y, Serikawa M, Tsuboi T, Kawamura R, Tsushima K, Nakamura S
. Usefulness of peroral cholangioscopy in the differential diagnosis of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma: a single-center retrospective study. BMC Gastroenterol. 2020; 20(1):287.
PMC: 7445926.
DOI: 10.1186/s12876-020-01429-2.
View
20.
. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol. 2022; 77(3):761-806.
DOI: 10.1016/j.jhep.2022.05.011.
View